[EN] HYDROCARBYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER [FR] PYRIDINES À SUBSTITUTION HYDROCARBYLSULFONYLE ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER
[EN] HETEROARYLSULFONYL-SUBSTITUTED PYRIDINES AND THEIR USE IN THE TREATMENT OF CANCER [FR] PYRIDINES À SUBSTITUTION HÉTÉROARYLSULFONYLE ET LEUR UTILISATION DANS LE TRAITEMENT DU CANCER
Amination of Aromatic Halides and Exploration of the Reactivity Sequence of Aromatic Halides
作者:Chu Yang、Feng Zhang、Guo-Jun Deng、Hang Gong
DOI:10.1021/acs.joc.8b02588
日期:2019.1.4
A base-promoted amination of aromatic halides has been developed using a limited amount of dimethylformamide (DMF) or amine as an amino source. Various arylhalides, including F, Cl, Br, and I, have been successfully aminated in good to excellent yields. Although the amination of aromatic halides with amines or DMF is usually considered as an aromatic nucleophilic substitution (SNAr) process, and the
Synthesis of Phenols from Aryl Ammonium Salts under Mild Conditions
作者:Pufan Ni、Lei Yang、Yi Shen、Lei Zhang、Yueyue Ma、Maolin Sun、Ruihua Cheng、Jinxing Ye
DOI:10.1021/acs.joc.2c01133
日期:2022.10.7
A general method for the synthesis of phenols from electron-deficient aryl ammonium salts or heteroaryl ammonium salts undermildconditions was developed. Benzaldehyde oxime, acetohydroxamic acid, and hydroxylamine hydrochloride were investigated as hydroxide surrogates respectively. With these hydroxide surrogates, a series of phenols were prepared in yields of 20–98%.
Pyridines and their use in the treatment of cancer
申请人:The United States of America, as represented by the Secretary, Department of Health and Human Services
公开号:US10899710B2
公开(公告)日:2021-01-26
There is provided compounds of formula (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3, R4 and n have meanings provided in the description, which compounds are useful in the treatment of cancers.
提供了式 (I) 的化合物或其药学上可接受的盐类,其中 L、R1、R2、R3、R4 和 n 的含义见说明,这些化合物可用于治疗癌症。
Heteroarylsulfonyl-substituted pyridines and their use in the treatment of cancer
申请人:Oblique Therapeutics AB
公开号:US11028067B2
公开(公告)日:2021-06-08
There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
提供了式 I (I)化合物或其药学上可接受的盐类,其中 L、R1、R2、R3 和 X 具有描述中提供的含义,这些化合物可用于治疗癌症。
Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer
申请人:Oblique Therapeutics AB
公开号:US11161815B2
公开(公告)日:2021-11-02
There is provided compounds of formula I (I) or pharmaceutically-acceptable salts thereof, wherein L, R1, R2, R3 and X have meanings provided in the description, which compounds are useful in the treatment of cancers.
提供了式 I (I)化合物或其药学上可接受的盐类,其中 L、R1、R2、R3 和 X 具有描述中提供的含义,这些化合物可用于治疗癌症。